Xirestomig is a monoclonal antibody targeting TNFRSF9 and CD274. This antibody is designed for specificity against these tumor necrosis factor receptor superfamily member 9 and programmed death-ligand 1 (PD-L1), implicated in immune response modulation. Xirestomig is utilized primarily in research focusing on the mechanisms of immune checkpoint regulation and potential therapeutic interventions in cancer immunotherapy.
Xirestomig is a monoclonal antibody targeting TNFRSF9 and CD274. This antibody is designed for specificity against these tumor necrosis factor receptor superfamily member 9 and programmed death-ligand 1 (PD-L1), implicated in immune response modulation. Xirestomig is utilized primarily in research focusing on the mechanisms of immune checkpoint regulation and potential therapeutic interventions in cancer immunotherapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
